TECTONIC THERAPEUTIC, INC. Operating Lease Right-of-Use Assets
TECTONIC THERAPEUTIC, INC. (TECX) had Operating Lease Right-of-Use Assets of $3.68 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $3.68M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $4.11M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $874.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $665.00K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $3.68M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $4.11M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $874.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $665.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.20M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.72M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $2.23M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.77M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.21M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $110.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.67M 10-K · filed 2025-03-20 | $432.00K 10-K · filed 2024-03-14 |
| 2023-09-30 | $912.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.27M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.86M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.06M 10-K · filed 2024-03-14 | |
| 2022-01-01 | $1.30M 10-K · filed 2023-03-23 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |